Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Down regulation of genes involved in T cell polarity and motility during the induction of heart allograft tolerance by allochimeric MHC I.

Lisik W, Tejpal N, Gong Y, Skelton TS, Ganachari M, Bremer EG, Kloc M, Ghobrial RM.

PLoS One. 2009 Dec 2;4(12):e8020. doi: 10.1371/journal.pone.0008020.

2.

Intragraft gene expression profile associated with the induction of tolerance by allochimeric MHC I in the rat heart transplantation model.

Lisik W, Gong Y, Tejpal N, Skelton TS, Bremer EG, Kloc M, Ghobrial RM.

Genesis. 2010 Jan;48(1):8-19. doi: 10.1002/dvg.20574.

PMID:
19882666
3.

Text mining of full-text journal articles combined with gene expression analysis reveals a relationship between sphingosine-1-phosphate and invasiveness of a glioblastoma cell line.

Natarajan J, Berrar D, Dubitzky W, Hack C, Zhang Y, DeSesa C, Van Brocklyn JR, Bremer EG.

BMC Bioinformatics. 2006 Aug 10;7:373.

4.

Regulation of murine TGFbeta2 by Pax3 during early embryonic development.

Mayanil CS, Pool A, Nakazaki H, Reddy AC, Mania-Farnell B, Yun B, George D, McLone DG, Bremer EG.

J Biol Chem. 2006 Aug 25;281(34):24544-52. Epub 2006 Jun 19.

5.

Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation.

Adarichev VA, Vermes C, Hanyecz A, Mikecz K, Bremer EG, Glant TT.

Arthritis Res Ther. 2005;7(2):R196-207. Epub 2004 Dec 14.

6.

Modulation of Growth Factor response in brain tumors by complex carbohydrates.

Rebbaa A, Chou PM, Bremer EG.

Bull Cancer. 2004 Apr;91(4):E15-60. Review.

7.

Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat.

Kozlowski DA, Miljan EA, Bremer EG, Harrod CG, Gerin C, Connor B, George D, Larson B, Bohn MC.

Brain Res. 2004 Aug 6;1016(2):170-81.

PMID:
15246853
8.

Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR.

Jiang L, Rampalli S, George D, Press C, Bremer EG, O'Gorman MR, Bohn MC.

Gene Ther. 2004 Jul;11(13):1057-67.

PMID:
15152187
9.

Gene expression profiling reveals a highly specialized genetic program of plasma cells.

Underhill GH, George D, Bremer EG, Kansas GS.

Blood. 2003 May 15;101(10):4013-21. Epub 2003 Jan 23.

PMID:
12543863
10.

High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1.

Hart ML, Saifuddin M, Uemura K, Bremer EG, Hooker B, Kawasaki T, Spear GT.

AIDS Res Hum Retroviruses. 2002 Nov 20;18(17):1311-7.

PMID:
12487819
11.

Regulation of growth factor receptors by gangliosides.

Miljan EA, Bremer EG.

Sci STKE. 2002 Nov 26;2002(160):re15. Review.

PMID:
12454318
12.
13.

Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis.

Tezak Z, Hoffman EP, Lutz JL, Fedczyna TO, Stephan D, Bremer EG, Krasnoselska-Riz I, Kumar A, Pachman LM.

J Immunol. 2002 Apr 15;168(8):4154-63.

14.

Quantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology.

Zhao Y, Yu M, Miller JW, Chen M, Bremer EG, Kabat W, Yogev R.

J Clin Microbiol. 2002 Feb;40(2):675-8.

15.

Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides.

Miljan EA, Meuillet EJ, Mania-Farnell B, George D, Yamamoto H, Simon HG, Bremer EG.

J Biol Chem. 2002 Mar 22;277(12):10108-13. Epub 2002 Jan 16.

16.

Microarray analysis detects novel Pax3 downstream target genes.

Mayanil CS, George D, Freilich L, Miljan EJ, Mania-Farnell B, McLone DG, Bremer EG.

J Biol Chem. 2001 Dec 28;276(52):49299-309. Epub 2001 Oct 5.

17.

Ganglioside modulates ligand binding to the epidermal growth factor receptor.

Wang X, Rahman Z, Sun P, Meuillet E, George D, Bremer EG, Al-Qamari A, Paller AS.

J Invest Dermatol. 2001 Jan;116(1):69-76.

18.

Overexpression of murine Pax3 increases NCAM polysialylation in a human medulloblastoma cell line.

Mayanil CS, George D, Mania-Farnell B, Bremer CL, McLone DG, Bremer EG.

J Biol Chem. 2000 Jul 28;275(30):23259-66.

19.

Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431.

Meuillet EJ, Mania-Farnell B, George D, Inokuchi JI, Bremer EG.

Exp Cell Res. 2000 Apr 10;256(1):74-82.

PMID:
10739654
20.

Expression of bisecting GlcNAc in pediatric brain tumors and its association with tumor cell response to vinblastine.

Rebbaa A, Chou PM, Vucic I, Mirkin BL, Tomita T, Bremer EG.

Clin Cancer Res. 1999 Nov;5(11):3661-8.

21.

Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431.

Meuillet EJ, Kroes R, Yamamoto H, Warner TG, Ferrari J, Mania-Farnell B, George D, Rebbaa A, Moskal JR, Bremer EG.

Cancer Res. 1999 Jan 1;59(1):234-40.

22.

Growth factor receptors as targets for therapy in pediatric brain tumors.

Meuillet EJ, Bremer EG.

Pediatr Neurosurg. 1998 Jul;29(1):1-13. Review.

PMID:
9755305
23.

alpha2,6-Sialyltransferase gene transfection into a human glioma cell line (U373 MG) results in decreased invasivity.

Yamamoto H, Kaneko Y, Rebbaa A, Bremer EG, Moskal JR.

J Neurochem. 1997 Jun;68(6):2566-76.

24.

alpha2,3-sialyltransferase mRNA and alpha2,3-linked glycoprotein sialylation are increased in malignant gliomas.

Yamamoto H, Saito T, Kaneko Y, Kersey D, Yong VW, Bremer EG, Mkrdichian E, Cerullo L, Leestma J, Moskal JR.

Brain Res. 1997 Apr 25;755(1):175-9.

PMID:
9163557
25.

Gene transfection-mediated overexpression of beta1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function.

Rebbaa A, Yamamoto H, Saito T, Meuillet E, Kim P, Kersey DS, Bremer EG, Taniguchi N, Moskal JR.

J Biol Chem. 1997 Apr 4;272(14):9275-9.

27.

Ganglioside GM3 inhibition of EGF receptor mediated signal transduction.

Rebbaa A, Hurh J, Yamamoto H, Kersey DS, Bremer EG.

Glycobiology. 1996 Jun;6(4):399-406.

PMID:
8842703
28.

Regulation of B cell function by the immunosuppressive agent leflunomide.

Siemasko KF, Chong AS, Williams JW, Bremer EG, Finnegan A.

Transplantation. 1996 Feb 27;61(4):635-42.

PMID:
8610393
29.

Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide.

Xu X, Williams JW, Bremer EG, Finnegan A, Chong AS.

J Biol Chem. 1995 May 26;270(21):12398-403.

30.

Preferential binding of the epidermal growth factor receptor to ganglioside GM3 coated plates.

Yednak MA, Bremer EG.

Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):369-78.

PMID:
8086043
31.

Altered RNA turnover in carcinogenesis. The diagnostic potential of modified base excretion.

Marvel CC, Del Rowe J, Bremer EG, Moskal JR.

Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):353-68. Review.

PMID:
7522008
32.

Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide.

Mattar T, Kochhar K, Bartlett R, Bremer EG, Finnegan A.

FEBS Lett. 1993 Nov 15;334(2):161-4.

33.
34.

Ganglioside GM3 inhibits the proliferation of cultured keratinocytes.

Paller AS, Arnsmeier SL, Alvarez-Franco M, Bremer EG.

J Invest Dermatol. 1993 Jun;100(6):841-5.

35.

Alteration in keratinocyte ganglioside content in basal cell carcinomas.

Paller AS, Arnsmeier SL, Robinson JK, Bremer EG.

J Invest Dermatol. 1992 Feb;98(2):226-32.

36.

Neurite outgrowth in dorsal root neuronal hybrid clones modulated by ganglioside GM1 and disintegrins.

Barletta E, Bremer EG, Culp LA.

Exp Cell Res. 1991 Mar;193(1):101-11.

PMID:
1825296
37.
38.

Inhibition of the alternative pathway of human complement by structural analogues of sialic acid.

Michalek MT, Mold C, Bremer EG.

J Immunol. 1988 Mar 1;140(5):1588-94.

PMID:
3346543
39.

Effect of gangliosides on activation of the alternative pathway of human complement.

Michalek MT, Bremer EG, Mold C.

J Immunol. 1988 Mar 1;140(5):1581-7.

PMID:
3346542
40.
41.

GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.

Raghavan S, Krusell A, Lyerla TA, Bremer EG, Kolodny EH.

Biochim Biophys Acta. 1985 Apr 25;834(2):238-48.

PMID:
3995063
42.

Developmental variation in monosialoganglioside content of embryonic chick retina and tectum.

Irwin LN, Bremer EG, Irwin CC, McCluer RH.

Dev Neurosci. 1985;7(4):239-46.

PMID:
3830676
43.

Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland.

Bremer EG, Levery SB, Sonnino S, Ghidoni R, Canevari S, Kannagi R, Hakomori S.

J Biol Chem. 1984 Dec 10;259(23):14773-7.

45.

Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation.

Bremer EG, Hakomori S, Bowen-Pope DF, Raines E, Ross R.

J Biol Chem. 1984 Jun 10;259(11):6818-25.

46.

Gangliosides as receptor modulators.

Bremer EG, Hakomori S.

Adv Exp Med Biol. 1984;174:381-94. No abstract available.

PMID:
6331135
47.

Acetonitrile-hydrochloric acid hydrolysis of gangliosides for high performance liquid chromatographic analysis of their long chain bases.

Kadowaki H, Bremer EG, Evans JE, Jungalwala FB, McCluer RH.

J Lipid Res. 1983 Oct;24(10):1389-97.

48.

GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-defined medium: ganglioside may regulate growth factor receptor function.

Bremer EG, Hakomori S.

Biochem Biophys Res Commun. 1982 Jun 15;106(3):711-8. No abstract available.

PMID:
6288031
49.

Effects of divalent cations on the glycolipids from cultured mouse neuroblastoma cells.

Bremer EG, Sapirstein VS, Savage T, McCluer RH.

J Neurochem. 1982 Feb;38(2):333-41.

PMID:
6809899
50.

Evidence for hydroxyacyl-ceramides and hydroxyacyl-cerebrosides in female rhesus monkey gingiva.

Wood N, Rabinowitz JL, Bremer EG, Fillios LC.

J Periodontol. 1980 Dec;51(12):716-8.

PMID:
6937645

Supplemental Content

Loading ...
Support Center